📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Contrasting requirements during disease evolution identify EZH2 as a therapeutic target in AML. (2019)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1084/jem.20181276

PubMed Identifier: 30890554

Publication URI: http://europepmc.org/abstract/MED/30890554

Type: Journal Article/Review

Volume: 216

Parent Publication: The Journal of experimental medicine

Issue: 4

ISSN: 0022-1007